Skip to main content
. 2018 Apr 15;24:2271–2279. doi: 10.12659/MSM.906361

Figure 2.

Figure 2

SIX1 siRNA and/or TAX treatment reduced the growth of HepG2 cells. (A) SIX1 siRNA transfection resulted in significantly lower expression of SIX1 in HepG2 cells; * p<0.05 compared with control group. (B) Growth of HepG2 cells in different groups. MTT assay saw obvious cell viability reduction in the SIX1 siRNA, TAX, and si-SIX1+TAX groups compared to control group; * p<0.05 compared with control group, # p<0.05 compared with SIX1 siRNA group, & p<0.05 compared with TAX group.